Raleukin (AMG-719) is a recombinant, nonglycosylated humaninterleukin-1 receptor (IL-1R)antagonist. Raleukin (AMG-719) is the first biological agent to block the pro-inflammatory effects^[1][2].

Combined Etanercept (5 mg/kg, ip) and Anakinra (100 mg/kg, ip. daily for 7 days) substantially improves marginal mass human islet engraftment in immunodeficient mice^[2].
Raleukin (AMG-719) enhances tumor growth inhibition in mice receiving peptide vaccination and β-(1-3),(1-6)-D-glucan^[3].

17257.60

Liquid

C₇₅₉H₁₁₈₆N₂₀₈O₂₃₂S₁₀

143090-92-0

阿那白滞素

Please store the product under the recommended conditions in the Certificate of Analysis.